Bioprinting Companies Unite to Form HU3DINKS Consortium

A new international consortium called HU3DINKS is rallying behind a single mission: to develop advanced human tissue-based bioinks for 3D bioprinting. Supported by IraSME, a German network of funding programs; FFG, Austria’s national funding agency for industrial research and development; and VLAIO, the Flemish agency for innovation and entrepreneurship, the consortium seeks to replace synthetic and animal-derived bioinks, aiming to lead in the bioprinting revolution.